These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 7927313

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S.
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.
    Umekita Y, Ohi Y, Sagara Y, Yoshida H.
    Int J Cancer; 2000 Nov 20; 89(6):484-7. PubMed ID: 11102891
    [Abstract] [Full Text] [Related]

  • 10. Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas.
    Ibrahim SO, Lillehaug JR, Johannessen AC, Liavaag PG, Nilsen R, Vasstrand EN.
    Oral Oncol; 1999 May 20; 35(3):302-13. PubMed ID: 10621852
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer.
    Lukes AS, Kohler MF, Pieper CF, Kerns BJ, Bentley R, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast RC, Berchuck A.
    Cancer; 1994 May 01; 73(9):2380-5. PubMed ID: 7909491
    [Abstract] [Full Text] [Related]

  • 16. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
    Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ.
    J Natl Cancer Inst; 1998 Jun 03; 90(11):824-32. PubMed ID: 9625170
    [Abstract] [Full Text] [Related]

  • 17. Molecular profile of advanced-stage transitional cell carcinoma of the ovary.
    Gershenson DM, Baker VV, Price JE, Hung MC, El-Naggar AK, Tortolero-Luna G, Silva EG.
    Am J Obstet Gynecol; 1997 Jul 03; 177(1):120-5. PubMed ID: 9240594
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.
    Umekita Y, Enokizono N, Sagara Y, Kuriwaki K, Takasaki T, Yoshida A, Yoshida H.
    Virchows Arch A Pathol Anat Histopathol; 1992 Jul 03; 420(4):345-51. PubMed ID: 1348890
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.
    Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB.
    Int J Gynecol Pathol; 2004 Apr 03; 23(2):129-37. PubMed ID: 15084841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.